Pulmonary Sarcoidosis Trial Flips the Playbook
A multicenter Dutch randomized trial published in the New England Journal of Medicine has shown that methotrexate can be used to replace prednisone as first-line therapy for symptomatic pulmonary ...
In Conversation With… Naomi Patel, MD MPH
“In just six months, more than 10% of patients on even moderate steroid regimens can develop new-onset diabetes.” Naomi Patel, MD MPH, a rheumatologist at Massachusetts General Hospital, is at the ...
Want a Steroid-Sparing Claim on Your Label? Start Here
Chronic glucocorticoid exposure, even at low doses, is now seen by regulators and clinicians as an unacceptable safety burden. Sponsors that prioritize steroid-toxicity from the outset position ...
In Conversation With… Kathy Perez
“When patients can track their own experience of steroid‑toxicity and take that data straight into the clinic, they stop being passive recipients and start driving the conversation.” Clinicians know ...
Sam Usage Data Shows Surge in User Adoption
New data presented at EULAR 2025 show Sam’s rapid user growth and increasing importance to patients. At the American College of Rheumatology (ACR) Annual Meeting in Washington, DC, Steritas released ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
